MediciNova Inc.

NASDAQ: MNOV · Real-Time Price · USD
1.41
-0.01 (-0.70%)
At close: May 30, 2025, 3:50 PM
1.39
-1.42%
After-hours: May 30, 2025, 04:00 PM EDT

MediciNova Statistics

Share Statistics

MediciNova has 49.05M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding 49.05M
Shares Change (YoY) 0%
Shares Change (QoQ) 0%
Owned by Institutions (%) 10.67%
Shares Floating n/a
Failed to Deliver (FTD) Shares 3,130
FTD / Avg. Volume 24.1%

Short Selling Information

The latest short interest is 180.55K, so 0.37% of the outstanding shares have been sold short.

Short Interest 180.55K
Short % of Shares Out 0.37%
Short % of Float 0.43%
Short Ratio (days to cover) 16.23

Valuation Ratios

The PE ratio is -9.32 and the forward PE ratio is null. MediciNova's PEG ratio is -0.26.

PE Ratio -9.32
Forward PE n/a
PS Ratio 0
Forward PS n/a
PB Ratio 1.96
P/FCF Ratio -9.68
PEG Ratio -0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for MediciNova.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.88, with a Debt / Equity ratio of 0.

Current Ratio 13.88
Quick Ratio 13.88
Debt / Equity 0
Debt / EBITDA -0.02
Debt / FCF -0.02
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-849,965.31
Employee Count 13
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 5.54K
Effective Tax Rate -0.05%

Stock Price Statistics

The stock price has increased by 3.68% in the last 52 weeks. The beta is 0.46, so MediciNova's price volatility has been higher than the market average.

Beta 0.46
52-Week Price Change 3.68%
50-Day Moving Average 1.43
200-Day Moving Average 1.73
Relative Strength Index (RSI) 44.74
Average Volume (20 Days) 12,988

Income Statement

Revenue n/a
Gross Profit -21.08K
Operating Income -12.68M
Net Income -11.05M
EBITDA -11.02M
EBIT -11.04M
Earnings Per Share (EPS) -0.23
Full Income Statement

Balance Sheet

The company has 40.36M in cash and 193.77K in debt, giving a net cash position of 40.17M.

Cash & Cash Equivalents 40.36M
Total Debt 193.77K
Net Cash 40.17M
Retained Earnings -426.75M
Total Assets 52.43M
Working Capital 35.55M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -10.64M and capital expenditures -895, giving a free cash flow of -10.64M.

Operating Cash Flow -10.64M
Capital Expenditures -895
Free Cash Flow -10.64M
FCF Per Share -0.22
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MNOV does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for MNOV is $9, which is 538.3% higher than the current price. The consensus rating is "Buy".

Price Target $9
Price Target Difference 538.3%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Scores

Altman Z-Score 4.96
Piotroski F-Score 2